Parallax Volatility Advisers, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 12,144 shares of REGN stock, worth $8.52 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

12,144

Previous 10,996 10.44%

Holding current value

$8.52 Million

Previous $11.6 Million 10.46%

% of portfolio

0.02%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $1.18 Million - $1.38 Million	1,148 Added 10.44%	12,144 $12.8 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $1.77 Million - $2.15 Million	-2,004 Reduced 15.42%	10,996 $11.6 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $11.7 Million - $12.9 Million	13,000 New	13,000 $12.5 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $1.8 Million - $2.28 Million	-3,141 Reduced 98.13%	60 $41,000
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $1.76 Million - $2.37 Million	3,201 New	3,201 $1.89 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $2.98 Million - $3.68 Million	-5,481 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $226,631 - $279,794	-417 Reduced 7.07%	5,481 $3.46 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $3.19 Million - $3.78 Million	5,552 Added 1604.62%	5,898 $3.57 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $165,491 - $210,361	346 New	346 $167,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $77,962 - $99,100	-163 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $88,794 - $107,288	163 New	163 $91,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $2,466 - $3,219	-5 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $3 Million - $4.42 Million	-8,934 Reduced 99.94%	5 $2,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $2.35 Million - $3.23 Million	8,588 Added 2446.72%	8,939 $3.36 Million
Q3 2019 Nov 14, 2019	SELL	$273.46 - $318.39 $64,536 - $75,140	-236 Reduced 40.2%	351 $97,000
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $729,526 - $1.01 Million	-2,435 Reduced 80.58%	587 $184,000
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $16.8 Million - $19.9 Million	-45,279 Reduced 93.74%	3,022 $1.24 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $9.29 Million - $11.1 Million	27,656 Added 133.96%	48,301 $18 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $3.64 Million - $4.41 Million	12,793 Added 162.93%	20,645 $7.12 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $1.44 Million - $1.79 Million	4,553 Added 138.01%	7,852 $2.7 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $79,615 - $104,328	-222 Reduced 6.31%	3,299 $1.24 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $1.52 Million - $1.77 Million	3,521	3,521 $1.57 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Regeneron Pharmaceuticals, Inc. Transaction History